Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment.

Front Pharmacol · 2020 · PMC7063971 · PMID 32194423

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

failed to reach statistical significanceP = 0.080so close (0.05 < p ≤ 0.1)

Similarly, the inhibitory effects in ES2/CP tumor treated with 25 and 50 mg/kg AZD8186 failed to reach statistical significance ( P = 0.080 and P = 0.080, respectively) relative to those treated with vehicle.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.